Polypeptides having phospholipase C activity and polynucleotides encoding same

US10954469B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10954469-B2
Application numberUS-201916423748-A
CountryUS
Kind codeB2
Filing dateMay 28, 2019
Priority dateMar 19, 2014
Publication dateMar 23, 2021
Grant dateMar 23, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a method of reducing the phospholipid content in an oil or fat composition and polypeptides having PI-specific phospholipase C activity as well as polypeptides having PC, PE-specific phospholipase C activity and combinations thereof capable of catalyzing this reduction. The invention also relates to polynucleotides encoding the polypeptides, nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for reducing the content of phospholipids in an oil composition, the method comprising a) contacting an oil composition containing a quantity of phospholipids with a phosphatidylinositol phospholipase C and a phosphatidylcholine and phosphatidylethanolamine-specific phospholipase C polypeptide (“a PC and PE-specific phospholipase C”) under conditions sufficient to hydrolyze the phospholipids to diglyceride and phosphate ester, wherein i) the phosphatidylinositol phospholipase C has at least 90% sequence identity to amino acid residues 26-322 of SEQ ID NO: 2 or amino acid residues 1-298 of SEQ ID NO: 3, and (ii) the PC and PE-specific phospholipase C has at least 90% sequence identity to amino acid residues 25-280 of SEQ ID NO: 38 or amino acid residues 36-280 of SEQ ID NO: 38; and b) separating the phosphate ester from the oil composition. 2. The method of claim 1 , wherein the oil is an edible oil. 3. The method of claim 1 , wherein the oil is selected from the group consisting of crude oil, water degummed oil, caustic refined oil and acid degummed oil. 4. The method of claim 1 , wherein the oil comprises phosphatidylcholine (PC), phosphatidylethanolamine (PE) and phosphatidyl inositol (PI). 5. The method of claim 4 , wherein the oil comprises at least 50 ppm phosphorus originating from phosphatidyl inositol (PI). 6. The method of claim 1 , wherein (a) the phosphatidylinositol phospholipase C has at least 95% sequence identity to amino acid residues 26-322 of SEQ ID NO: 2 or amino acid residues 1-298 of SEQ ID NO: 3; and (b) the PC and PE-specific phospholipase C polypeptide has at least 95% sequence identity to amino acid residues 25-280 of SEQ ID NO: 38 or amino acid residues 36-280 of SEQ ID NO: 38. 7. The method of claim 1 , wherein (a) the phosphatidylinositol phospholipase C comprises amino acid residues 26-322 of SEQ ID NO: 2 or amino acid residues 1-298 of SEQ ID NO: 3; and (b) the PC and PE-specific phospholipase C polypeptide comprises to amino acid residues 25-280 of SEQ ID NO: 38 or amino acid residues 36-280 of SEQ ID NO: 38. 8. The method of claim 1 , wherein (a) the phosphatidylinositol phospholipase C is a fragment of amino acid residues 26-322 of SEQ ID NO: 2 or a fragment of amino acid residues 1-298 of SEQ ID NO: 3; and (b) the PC and PE-specific phospholipase C polypeptide is a fragment of amino acid residues 25-280 of SEQ ID NO: 38 or a fragment of amino acid residues 36-280 of SEQ ID NO: 38. 9. The method of claim 1 , wherein the oil is contacted with 0.5-200 mg enzyme protein (EP)/Kg oil of the phosphatidylinositol phospholipase C and with 0.5-200 mg enzyme protein (EP)/Kg oil of the PC and PE-specific phospholipase C. 10. The method of claim 1 , wherein the oil is contacted with 1-25 mg enzyme protein (EP)/Kg oil of the phosphatidylinositol phospholipase C and with 1-25 mg enzyme protein (EP)/Kg oil of the PC and PE-specific phospholipase C. 11. The method of claim 1 , wherein the oil is contacted with 2-15 mg enzyme protein (EP)/Kg oil of the phosphatidylinositol phospholipase C and with 2-15 mg enzyme protein (EP)/Kg oil of the PC and PE-specific phospholipase C.

Assignees

Inventors

Classifications

  • Phospholipase C (3.1.4.3) · CPC title

  • C11B3/003Primary

    by enzymes or microorganisms, living or dead · CPC title

  • C12N9/16Primary

    acting on ester bonds (3.1) · CPC title

  • Phosphoinositide phospholipase C (3.1.4.11) · CPC title

  • Triglyceride splitting, e.g. by means of lipase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10954469B2 cover?
The present invention relates to a method of reducing the phospholipid content in an oil or fat composition and polypeptides having PI-specific phospholipase C activity as well as polypeptides having PC, PE-specific phospholipase C activity and combinations thereof capable of catalyzing this reduction. The invention also relates to polynucleotides encoding the polypeptides, nucleic acid constru…
Who is the assignee on this patent?
Novozymes As
What technology area does this patent fall under?
Primary CPC classification C11B3/003. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).